Back

EYLEA franchise generated $5.97 billion in U.S. sales in 2024

Verifying
  • ResearchAndMarkets.com added a report covering EYLEA and EYLEA HD across seven pharmaceutical markets.
  • The U.S. franchise generated approximately $5.97 billion in sales during 2024.
  • The forecast covers historical sales from 2020 through 2034, including approved and potential indications.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.